Skip to main content
OpenTrials

Clinical trial condition

Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

695 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Completed

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

NCT01471782

Conditions
Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • Children's Hospital Denver Aurora, Colorado, United States
  • Children's Healthcare of Atlanta at Egleston Atlanta, Georgia, United States
  • Washington University St Louis, Missouri, United States
  • Memorial Sloan Kettering New York, United States
View all 30 locations
View Trial Details
Completed

S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

NCT00005089

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
View all 92 locations
View Trial Details
Completed

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

NCT00053053

Conditions
Body Weight, Body Weight Changes, Burkitt Lymphoma, +44 more
Locations
  • Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Comprehensive Cancer Institute Huntsville, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Montgomery Cancer Center Montgomery, Alabama, United States
View all 250 locations
View Trial Details
Completed

Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

NCT00005601

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
View all 21 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

NCT00006125

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Diego San Diego, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
View all 76 locations
View Trial Details
Completed

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00003863

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Naval Medical Center - San Diego San Diego, California, United States
  • Veterans Affairs Medical Center - San Diego San Diego, California, United States
View all 69 locations
View Trial Details
Completed

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

NCT00006348

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +100 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
  • Siouxland Hematology-Oncology Sioux City, Iowa, United States
View Trial Details

Related conditions